QMCO Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
QMCO is not a good buy right now for an impatient investor. The stock is in a confirmed downtrend, sitting below key levels with weakening momentum, while headline risk is elevated due to investigations and a required financial restatement. With no Intellectia buy signals (AI Stock Picker and SwingMax both inactive), heavy insider selling, and deteriorating recent-quarter fundamentals, the risk/reward skews negative in the near term. I would avoid new longs here and would sell/step aside rather than trying to catch an oversold bounce ahead of earnings (2026-02-11).
Trend is bearish and momentum is deteriorating. Moving averages are stacked bearishly (SMA_200 > SMA_20 > SMA_5), indicating a sustained downtrend. MACD histogram is negative (-0.0875) and expanding to the downside, confirming increasing bearish momentum. RSI_6 at ~20.69 signals deeply oversold conditions, which can allow short-lived dead-cat bounces, but oversold alone is not a buy signal when trend/momentum are bearish. Key levels: Current price 6.335 is below S1 (6.415), suggesting a breakdown of near support; next support is S2 at 5.977. Overhead resistance is the pivot at 7.124 and then R1 at 7.832. Given the breakdown below S1 and negative MACD, odds favor further weakness toward ~5.98 before any sustainable reversal.
could reset expectations if the company shows credible progress (but this cuts both ways).
Event-driven/legal/accounting overhang: executives under investigation for alleged fiduciary breaches and improper revenue recognition, with a stated need to restate financial statements (high confidence negative catalyst).
Ongoing shareholder-law-firm investigations and potential litigation can pressure valuation and restrict buyer appetite.
Heavy insider selling: insider selling amount increased ~1809% over the last month (strong negative signal).
Bearish technical setup: downtrend intact, MACD worsening, price below near support.
Fundamental pressure: revenue and gross margin declined YoY in the latest reported quarter.
No supportive Intellectia signals:
Intellectia Proprietary Trading Signals
Congress/influential trading: no recent congress trading data available (no supportive political-flow catalyst).
Latest quarter provided: 2026/Q2. Revenue fell to 62.715M (-12.71% YoY), showing top-line contraction. Gross margin dropped to 37.55 (-11.96% YoY), indicating profitability pressure at the core business level. Net income improved YoY to -46.456M (still a large loss), and EPS improved to -3.49 YoY, but both remain meaningfully negative—improvement appears more like loss-narrowing rather than a return to profitability. Overall growth trend is negative on sales and margin, which is not supportive for a near-term long entry, especially with accounting-restatement risk in the news.
Recent analyst trend is mixed. On 2025-11-14, Northland upgraded to Outperform with a $13 price target, citing booking momentum and believing guidance may be conservative. The same day, Lake Street maintained Hold and cut its price target to $9 from $10, highlighting that the company is forecasting AEBITDA losses in three of the next five quarters. Wall Street pros: potential operational turnaround (new CEO actions), bookings/backlog strength, and upside implied by the $13 bull target. Wall Street cons: continued expected losses over multiple quarters and tempered near-term confidence shown by the Hold rating and PT cut. Net analyst takeaway: upside exists if execution improves, but consensus confidence is not strong enough to offset the current legal/accounting and trend risks.
